Search research articles
Contact Us
Filters
Showing results (31-40 of 100) with videos related to
Page
of 10
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 9, 2007
A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice
Hendrik Fuchs, Christopher Bachran, Tongyu Li, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 9, 2008
Small cleavable adapters enhance the specific cytotoxicity of a humanized immunotoxin directed against CD64-positive cells
Christian Hetzel, Christopher Bachran, Rainer Fischer, et al.
Molecular Pharmaceutics
|
October 11, 2011
The endocytic uptake pathways of targeted toxins are influenced by synergistically acting Gypsophila saponins
Diana Bachran, Stefanie Schneider, Christopher Bachran, et al.
ACS Nano
|
April 17, 2010
Biocompatible protein nanocontainers for controlled drugs release
Yongsheng Han, Dmitry Shchukin, Juan Yang, et al.
ACS Polymers Au
|
February 16, 2026
Copolymers of NVAm and NVP for Efficient Gene Delivery
Tom Fielitz, Christopher Raab, Vitalii Tkachenko, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
March 28, 2006
The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure
Christopher Bachran, Mark Sutherland, Iring Heisler, et al.
Planta Medica
|
May 20, 2009
A simple method for isolation of Gypsophila saponins for the combined application of targeted toxins and saponins in tumor therapy
Alexander Weng, Diana Bachran, Cornelia Görick, et al.
Molecular Oncology
|
July 30, 2017
Targeted dianthin is a powerful toxin to treat pancreatic carcinoma when applied in combination with the glycosylated triterpene SO1861
Cheenu Bhargava, Horst Dürkop, Xiangli Zhao, et al.
Biomedicines
|
May 25, 2017
Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor Therapies
Hendrik Fuchs, Nicole Niesler, Alexandra Trautner, et al.
BMC Biotechnology
|
April 29, 2024
A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861
Finn J Schulze, Mazdak Asadian-Birjand, Michael Pradela, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 100) with videos related to
Sort By:
Page
of 10
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 9, 2007
A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice
Hendrik Fuchs, Christopher Bachran, Tongyu Li, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 9, 2008
Small cleavable adapters enhance the specific cytotoxicity of a humanized immunotoxin directed against CD64-positive cells
Christian Hetzel, Christopher Bachran, Rainer Fischer, et al.
Molecular Pharmaceutics
|
October 11, 2011
The endocytic uptake pathways of targeted toxins are influenced by synergistically acting Gypsophila saponins
Diana Bachran, Stefanie Schneider, Christopher Bachran, et al.
ACS Nano
|
April 17, 2010
Biocompatible protein nanocontainers for controlled drugs release
Yongsheng Han, Dmitry Shchukin, Juan Yang, et al.
ACS Polymers Au
|
February 16, 2026
Copolymers of NVAm and NVP for Efficient Gene Delivery
Tom Fielitz, Christopher Raab, Vitalii Tkachenko, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
March 28, 2006
The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure
Christopher Bachran, Mark Sutherland, Iring Heisler, et al.
Planta Medica
|
May 20, 2009
A simple method for isolation of Gypsophila saponins for the combined application of targeted toxins and saponins in tumor therapy
Alexander Weng, Diana Bachran, Cornelia Görick, et al.
Molecular Oncology
|
July 30, 2017
Targeted dianthin is a powerful toxin to treat pancreatic carcinoma when applied in combination with the glycosylated triterpene SO1861
Cheenu Bhargava, Horst Dürkop, Xiangli Zhao, et al.
Biomedicines
|
May 25, 2017
Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor Therapies
Hendrik Fuchs, Nicole Niesler, Alexandra Trautner, et al.
BMC Biotechnology
|
April 29, 2024
A cleavable peptide adapter augments the activity of targeted toxins in combination with the glycosidic endosomal escape enhancer SO1861
Finn J Schulze, Mazdak Asadian-Birjand, Michael Pradela, et al.
Page
of 10